- Home
- LITB vs COEP Comparison
LITB vs COEP Comparison
Compare LITB & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- COEP
- Stock Information
- Founded
- LITB 2007
- COEP 2017
- Country
- LITB Singapore
- COEP United States
- Employees
- LITB N/A
- COEP N/A
- Industry
- LITB Catalog/Specialty Distribution
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LITB Consumer Discretionary
- COEP Health Care
- Exchange
- LITB Nasdaq
- COEP Nasdaq
- Market Cap
- LITB 32.7M
- COEP 32.0M
- IPO Year
- LITB N/A
- COEP N/A
- Fundamental
- Price
- LITB $1.16
- COEP $7.66
- Analyst Decision
- LITB
- COEP
- Analyst Count
- LITB 0
- COEP 0
- Target Price
- LITB N/A
- COEP N/A
- AVG Volume (30 Days)
- LITB 13.1K
- COEP 26.1K
- Earning Date
- LITB 08-01-2025
- COEP 08-15-2025
- Dividend Yield
- LITB N/A
- COEP N/A
- EPS Growth
- LITB N/A
- COEP N/A
- EPS
- LITB 0.08
- COEP N/A
- Revenue
- LITB $231,136,000.00
- COEP $62,874.00
- Revenue This Year
- LITB N/A
- COEP N/A
- Revenue Next Year
- LITB N/A
- COEP N/A
- P/E Ratio
- LITB $15.16
- COEP N/A
- Revenue Growth
- LITB N/A
- COEP N/A
- 52 Week Low
- LITB $0.91
- COEP $2.31
- 52 Week High
- LITB $5.76
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- LITB 44.38
- COEP 33.94
- Support Level
- LITB $1.16
- COEP $7.50
- Resistance Level
- LITB $1.32
- COEP $8.62
- Average True Range (ATR)
- LITB 0.08
- COEP 0.48
- MACD
- LITB 0.01
- COEP -0.15
- Stochastic Oscillator
- LITB 14.71
- COEP 3.77
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.